Jasper Therapeutics (JSPR) Other Operating Expenses (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Other Operating Expenses of -$15.8 million for Q2 2025, down 154.05% year-over-year from $29.2 million in Q2 2024, and down 61.57% quarter-over-quarter from -$9.8 million in Q1 2025.
Jasper Therapeutics (JSPR) Other Operating Expenses (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$15.8 million for Q2 2025.
- In Q2 2025, Other Operating Expenses fell 154.05% year-over-year to -$15.8 million; the TTM figure through Dec 2025 stood at -$25.5 million (down 107.27% YoY), while the FY2024 annual figure was -$34.3 million, up 6.82% from the prior year.
- Other Operating Expenses for Q2 2025 stood at -$15.8 million, down from -$9.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was $8.4 million in Q4 2022, with the low at -$15.8 million in Q2 2025.
- The 4-year median for Other Operating Expenses is -$477500.0 (2022), against an average of -$2.6 million.
- Peak annual rise in Other Operating Expenses reached 8625.25% in 2022, while the deepest fall reached 493.75% in 2022.
- Jasper Therapeutics' Other Operating Expenses stood at -$99000.0 in 2021, then soared by 8625.25% to $8.4 million in 2022, then sank by 173.54% to -$6.2 million in 2024, then sank by 154.05% to -$15.8 million in 2025.
- Business Quant data shows JSPR's Other Operating Expenses at -$15.8 million in Q2 2025, -$9.8 million in Q1 2025, and -$6.2 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Jasper Therapeutics | 20.38 Mn | 20.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -15.77 Mn |
| Mar 31, 2025 | -9.76 Mn |
| Jun 30, 2024 | -6.21 Mn |
| Mar 31, 2024 | -6.11 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Sep 30, 2022 | -475,000.00 |
| Jun 30, 2022 | -480,000.00 |
| Mar 31, 2022 | -556,000.00 |
| Dec 31, 2021 | -99,000.00 |
| Sep 30, 2021 | -80,000.00 |
| Jun 30, 2021 | -129,000.00 |
| Mar 31, 2021 | -128,000.00 |
| Dec 31, 2020 | 4.30 Mn |
| Sep 30, 2020 | 4.20 Mn |